China Universal Asset Management Company’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,885
Closed -$11.7K 486
2025
Q1
$11.7K Sell
12,885
-736
-5% -$670 ﹤0.01% 472
2024
Q4
$37.7K Buy
+13,621
New +$37.7K ﹤0.01% 464